韓國政府與私營部門利益相關者舉行了協商會議，以促進人工智能（AI）在藥物開發中的使用

會議將經濟和財政部以及其他相關政府機構的官員與領先的製藥公司一起

South Korean government officials met with private sector stakeholders on Thursday to discuss promoting the use of artificial intelligence (AI) in drug development in response to intensifying global competition in the bio-health sector, the Ministry of Economy and Finance said.

經濟和金融部表示，韓國政府官員周四會見了私營部門利益相關者，討論了促進人工智能（AI）在藥物開發中的使用，以響應加強生物健康部門的全球競爭。

The meeting brought together officials from the Ministry of Economy and Finance and other relevant government agencies, alongside leading pharmaceutical companies, including Daewoong Pharmaceutical, Yonhap news agency reported.

據Yonhap新聞社報導，該會議將來自經濟和財政部以及其他相關政府機構的官員與包括Daewoong Pharmaceutical在內的領先的製藥公司一起。

As per the Ministry, the discussions were focused on boosting AI-based drug development and promoting effective data usage, with sessions serving as a platform to listen to challenges faced by the pharmaceutical industry and to explore directions for public-private cooperation.

根據該部的，討論的重點是提高基於AI的藥物開發並促進有效的數據使用，其會議是傾聽製藥行業面臨的挑戰的平台，並探索了公私合作的方向。

Global AI biotechnology market is projected to grow over 19 per cent annually to reach $7.75 billion by 2029. South Korea currently ranks third globally in the number of AI bio-related patent applications.

到2029年，全球AI生物技術市場預計每年將增長19％以上，達到77.5億美元。目前，韓國在與AI Bio相關的專利申請的數量中排名全球第三。

“AI is rapidly permeating the entire biotechnology industry,” the finance ministry said. “It is emerging as a core technology across areas, such as new drug development, protein structure prediction and design, and gene therapy.”

財政部說：“ AI正在迅速滲透到整個生物技術行業。” “它正在成為跨領域的核心技術，例如新藥開發，蛋白質結構預測和設計以及基因治療。”

The ministry emphasised that countries are now in fierce competition to preemptively secure AI capabilities and apply them effectively in the bio-health field.

該部強調，國家現在處於激烈的競爭中，以先發製人的AI能力，並在生物健康領域有效地應用它們。

In particular, AI-powered drug development is revolutionizing the traditional pharmaceutical research and development process, the ministry said.

該部說，特別是AI驅動的藥物開發正在徹底改變傳統的製藥研究和開發過程。

Meanwhile, South Korea has reported plans to funnel 60 billion won (nearly $40.4 million) by 2028 to expand infrastructure for the development of materials and components technologies essential for advanced industries, such as AI, Yonhap reported.

同時，韓國報告了計劃在2028年匯入600億韓元（近40040萬美元）的計劃，以擴大基礎設施，以開發材料和組件技術對高級行業必不可少的材料和組件技術，例如AI，例如AI。

According to the Ministry of Trade, Industry, and Energy, the investment will be used to build research facilities and equipment for the development and testing of technologies related to materials and components essential for AI, advanced bio, and other future industries.

根據貿易，工業和能源部的說法，該投資將用於建造研究設施和設備，以開發和測試與AI，Advanced Bio和其他未來行業所必需的材料和組件相關的技術。

In detail, the government will support the construction of infrastructure for the development of core materials for next-generation AI chips, messenger RNA-based drugs, and others, the Ministry said.

該部稱詳細，政府將支持基礎設施的建設，以開發下一代AI芯片，基於Messenger RNA的藥物等核心材料。